Avelino Alvarez
Pediatrics · Laredo, TXNPI 1114097524
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Tris Pharma Inc accounts for 89.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $5,844 and has fallen 92.5% since, to $440 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $67.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$10K
- Collegium Pharmaceutical, Inc.$278
- Ironshore Pharmaceuticals Inc.$257
- GSK$145
- Cumberland Pharmaceuticals, Inc.$139
- Pfizer$69
- plus $336 from 13 others
What the payments were for
- Food & beverage$11,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 101 | $10,203 |
| Collegium Pharmaceutical, Inc. | 15 | $278 |
| Ironshore Pharmaceuticals Inc. | 15 | $257 |
| GSK | 5 | $145 |
| Cumberland Pharmaceuticals, Inc. | 10 | $139 |
| Pfizer | 4 | $69 |
| Merck | 4 | $67 |
| Kyowa Kirin, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Corium, LLC | 2 | $34 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Seqirus USA Inc | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| AstraZeneca | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$3,256
- Quillivant XR$1,912
- Quillivant$1,251
- Quillichew ER$570
How this compares
$11,426 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Laredo
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
- Ralph DeberardinisDallas$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.